Vol 2023, No 2 (2023)

Table of Contents

Licensing

Takeda Signs US$1.13 B Deal with Hutchmed for Colorectal Cancer Drug Abstract pdf html
Lucy Haggerty
Amgen Signs US$2 B Licensing Agreement with Synaffix for Next-Generation ADCs Abstract pdf html
Lalit Mishra & Lucy Haggerty
UniQure Pays US$10 M Upfront for Apic Bio’s ALS Gene Therapy Abstract pdf html
Lucy Haggerty
Karuna Pays US$15 M Upfront for Goldfinch Bio’s TRPC4/5 Inhibitors Abstract pdf html
Lucy Haggerty

Mergers & Acquisitions

Sun Pharma Acquires Concert Pharmaceuticals to Broaden its Dermatology Portfolio Abstract pdf html
Ayush Saxena
Ono Pharmaceutical Acquires Multiple Research-Stage Oncology Programmes from KSQ Therapeutics Abstract pdf html
Ashish Tripathi


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.